Unveiling the impact of lipid metabolism on triple-negative breast cancer growth and treatment options

被引:0
作者
Cai, Xin-xian [1 ,2 ]
Zhang, Zhe-zhong [1 ]
Yang, Xiao-xiao [1 ]
Shen, Wen-rui [1 ,3 ]
Yuan, Liu-wei [1 ,2 ]
Ding, Xi [1 ]
Yu, Ying [1 ]
Cai, Wen-yu [1 ]
机构
[1] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Zhejiang Prov Hosp Chinese Med, Hangzhou, Peoples R China
[2] Zhejiang Chinese Med Univ, Sch Med Technol & Informat Engn, Hangzhou, Peoples R China
[3] Zhejiang Chinese Med Univ, Clin Med Coll 1, Hangzhou, Peoples R China
关键词
triple-negative breast cancer; lipid metabolism; energy metabolism; recurrence of metastases; cell death; FATTY-ACID OXIDATION; TUMOR MICROENVIRONMENT; INHIBITION; PEROXIDATION; CHOLESTEROL; CELLS; IDENTIFICATION; FERROPTOSIS; DYSFUNCTION; APOPTOSIS;
D O I
10.3389/fonc.2025.1579423
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Triple-negative breast cancer (TNBC) is a subtype of breast cancer associated with poor prognosis and limited targeted treatment options. Lipid metabolism plays a pivotal role in the initiation, progression, and metastasis of TNBC by supporting cancer cell energy production, facilitating membrane biosynthesis, and regulating signal transduction. Dysregulation of lipid metabolism promotes tumor cell proliferation and contributes to processes such as epithelial-mesenchymal transition (EMT), angiogenesis, and immune evasion. Targeting lipid metabolism-such as inhibiting fatty acid synthase (FASN) and lipid metabolic byproducts-has emerged as a promising therapeutic strategy. The integration of multi-omics approaches and advanced imaging technologies can further elucidate the interactions between lipid metabolism and the tumor microenvironment, thereby supporting precision oncology. Future research should explore the role of lipid metabolism in distinct TNBC subtypes, optimize therapeutic strategies, and improve patient outcomes, particularly for those who are unresponsive to conventional treatments.
引用
收藏
页数:12
相关论文
共 79 条
[1]   PTU, a novel ureido-fatty acid, inhibits MDA-MB-231 cell invasion and dissemination by modulating Wnt5a secretion and cytoskeletal signaling [J].
al-Zubaidi, Yassir ;
Chen, Yongjuan ;
Rahman, Md. Khalilur ;
Umashankar, Bala ;
Choucair, Hassan ;
Bourget, Kirsi ;
Chung, Long ;
Qi, Yanfei ;
Witting, Paul K. ;
Anderson, Robin L. ;
O'Neill, Geraldine M. ;
Dunstan, Colin R. ;
Rawling, Tristan ;
Murray, Michael .
BIOCHEMICAL PHARMACOLOGY, 2021, 192
[2]   Imaging of cancer lipid metabolism in response to therapy [J].
Arlauckas, Sean Philip ;
Browning, Elizabeth Anne ;
Poptani, Harish ;
Delikatny, Edward James .
NMR IN BIOMEDICINE, 2019, 32 (10)
[3]   Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment [J].
Baek, Mokryun L. ;
Lee, Junegoo ;
Pendleton, Katherine E. ;
Berner, Mariah J. ;
Goff, Emily B. ;
Tan, Lin ;
Martinez, Sara A. ;
Mahmud, Iqbal ;
Wang, Tao ;
Meyer, Matthew D. ;
Lim, Bora ;
Barrish, James P. ;
Porter, Weston ;
Lorenzi, Philip L. ;
Echeverria, Gloria V. .
ONCOGENE, 2023, 42 (14) :1117-1131
[4]   Spatial Transcriptomic Analysis of a Diverse Patient Cohort Reveals a Conserved Architecture in Triple-Negative Breast Cancer [J].
Bassiouni, Rania ;
Idowu, Michael O. ;
Gibbs, Lee D. ;
Robila, Valentina ;
Grizzard, Pamela J. ;
Webb, Michelle G. ;
Song, Jiarong ;
Noriega, Ashley ;
Craig, David W. ;
Carpten, John D. .
CANCER RESEARCH, 2023, 83 (01) :34-48
[5]   Achieving Life through Death: Redox Biology of Lipid Peroxidation in Ferroptosis [J].
Bayir, Hulya ;
Anthonymuthu, Tamil S. ;
Tyurina, Yulia Y. ;
Patel, Sarju J. ;
Amoscato, Andrew A. ;
Lamade, Andrew M. ;
Yang, Qin ;
Vladimirov, Georgy K. ;
Philpott, Caroline C. ;
Kagan, Valerian E. .
CELL CHEMICAL BIOLOGY, 2020, 27 (04) :387-408
[6]   Cancer Focus Lipid metabolism and cancer [J].
Bian, Xueli ;
Liu, Rui ;
Meng, Ying ;
Xing, Dongming ;
Xu, Daqian ;
Lu, Zhimin .
JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (01)
[7]   Secreted Factors from Adipose Tissue Reprogram Tumor Lipid Metabolism and Induce Motility by Modulating PPARα/ANGPTL4 and FAK [J].
Bluecher, Christina ;
Iberl, Sabine ;
Schwagarus, Nancy ;
Mueller, Silvana ;
Liebisch, Gerhard ;
Hoering, Marcus ;
Hidrobo, Maria Soledad ;
Ecker, Josef ;
Spindler, Nick ;
Dietrich, Arne ;
Burkhardt, Ralph ;
Stadler, Sonja C. .
MOLECULAR CANCER RESEARCH, 2020, 18 (12) :1849-1862
[8]   Pathology of triple negative breast cancer [J].
Borri, Filippo ;
Granaglia, Annarita .
SEMINARS IN CANCER BIOLOGY, 2021, 72 :136-145
[9]   Fatty acid synthase - Modern tumor cell biology insights into a classical oncology target [J].
Buckley, Douglas ;
Duke, Gregory ;
Heuer, Timothy S. ;
O'Farrell, Marie ;
Wagman, Allan S. ;
McCulloch, William ;
Kemble, George .
PHARMACOLOGY & THERAPEUTICS, 2017, 177 :23-31
[10]   RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype [J].
Cai, Demin ;
Wang, Junjian ;
Gao, Bei ;
Li, Jin ;
Wu, Feng ;
Zou, June X. ;
Xu, Jianzhen ;
Jiang, Yuclian ;
Zou, Hongye ;
Huang, Zenghong ;
Borowsky, Alexander D. ;
Bold, Richard J. ;
Lara, Primo N. ;
Li, Jian Jian ;
Chen, Xinbin ;
Lam, Kit S. ;
To, Ka-Fai ;
Kung, Hsing-Jien ;
Fiehn, Oliver ;
Zhao, Ruqian ;
Evans, Ronald M. ;
Chen, Hong-Wu .
NATURE COMMUNICATIONS, 2019, 10 (1)